← All Sponsors
SPONSOR

Rapport Therapeutics Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2

Rapport Therapeutics Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Focal Epilepsy, Epilepsy, Refractory Focal Epilepsy, Seizure.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Rapport Therapeutics Inc.

How many clinical trials has Rapport Therapeutics Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Rapport Therapeutics Inc., of which 1 are actively recruiting participants. These trials cover conditions including Focal Epilepsy, Epilepsy, Refractory Focal Epilepsy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Rapport Therapeutics Inc. research focus on?
Rapport Therapeutics Inc. clinical trials span Focal Epilepsy, Epilepsy, Refractory Focal Epilepsy, Seizure, Focal Seizure, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Rapport Therapeutics Inc. clinical trial?
To participate in a Rapport Therapeutics Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rapport Therapeutics Inc. trials with current recruitment status updated daily.

Clinical Trials by Rapport Therapeutics Inc.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology